• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多体素磁共振波谱术可识别高级别胶质瘤中癌干细胞样细胞的富集灶。

Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas.

作者信息

He Tao, Qiu Tianming, Wang Xiaodong, Gui Hongxing, Wang Xilong, Hu Qikuan, Xia Hechun, Qi Gaoyang, Wu Jinsong, Ma Hui

机构信息

Clinical Medicine College, Ningxia Medical University; Department of Neurosurgery, General Hospital of Ningxia Medical University; Ningxia Key Laboratory of Cerebrocranial Diseases, The National Key Laboratory Incubation Base, Yinchuan.

Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai.

出版信息

Onco Targets Ther. 2017 Jan 4;10:195-203. doi: 10.2147/OTT.S118834. eCollection 2017.

DOI:10.2147/OTT.S118834
PMID:28115854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5221654/
Abstract

OBJECTIVE

This study investigated the correlation between choline/creatine (Cho/Cr) ratios determined by multivoxel proton magnetic resonance spectroscopy (H-MRS) and the distribution of cancer stem-like cells (CSLCs) in high-grade gliomas.

PATIENTS AND METHODS

Sixteen patients with high-grade gliomas were recruited and underwent H-MRS examination before surgery to identify distinct tumor regions with variable Cho/Cr ratios. Using intraoperative neuronavigation, tumor tissues were accurately sampled from regions with high and low Cho/Cr ratios within each tumor. The distribution of CSLCs in samples from glioma tissue regions with different Cho/Cr ratios was quantified by neurosphere culture, immunohistochemistry, and Western blot.

RESULTS

The mean neurosphere formation rate in tissues with high Cho/Cr ratios was significantly increased compared with that in low Cho/Cr ratio tissues (13.94±5.94 per 100 cells vs 8.04±3.99 per 100 cells, <0.001). Immunohistochemistry indicated that tissues with high Cho/Cr ratios had elevated expression of CD133, nestin, and CD15, relative to low Cho/Cr ratio tissue samples (23.6%±3.8% vs 18.3%±3.3%, 25.2%±4.5% vs 19.8%±2.8%, 24.5%±3.8% vs 17.8%±2.2%, respectively; all <0.001). Western blot demonstrated that relative CD133 and nestin protein expression in high Cho/Cr ratio regions was significantly higher than that in low Cho/Cr ratio tissue samples (0.50±0.17 vs 0.30±0.08, 0.45±0.13 vs 0.27±0.07, respectively; both <0.001). The protein expression levels of CD133 and nestin were highly correlated with Cho/Cr ratios (=0.897 and =0.861, respectively).

CONCLUSION

Cho/Cr ratios correlate with the distribution of CSLCs in high-grade gliomas, and this may assist in identifying foci enriched with CSLCs and thus improve the management of high-grade gliomas.

摘要

目的

本研究调查了多体素质子磁共振波谱(H-MRS)测定的胆碱/肌酸(Cho/Cr)比值与高级别胶质瘤中癌症干细胞样细胞(CSLCs)分布之间的相关性。

患者与方法

招募了16例高级别胶质瘤患者,术前进行H-MRS检查,以确定具有不同Cho/Cr比值的不同肿瘤区域。使用术中神经导航,从每个肿瘤内Cho/Cr比值高和低的区域准确采集肿瘤组织。通过神经球培养、免疫组织化学和蛋白质印迹法对来自不同Cho/Cr比值的胶质瘤组织区域样本中的CSLCs分布进行定量分析。

结果

与Cho/Cr比值低的组织相比,Cho/Cr比值高的组织中神经球形成率显著增加(每100个细胞中分别为13.94±5.94个和8.04±3.99个,<0.001)。免疫组织化学表明,与Cho/Cr比值低的组织样本相比,Cho/Cr比值高的组织中CD133、巢蛋白和CD15的表达升高(分别为23.6%±3.8%对18.3%±3.3%、25.2%±4.5%对19.8%±2.8%、24.5%±3.8%对17.8%±2.2%;均<0.001)。蛋白质印迹法表明,Cho/Cr比值高的区域中CD133和巢蛋白的相对蛋白表达显著高于Cho/Cr比值低的组织样本(分别为0.50±0.17对0.30±0.08、0.45±0.13对0.27±0.07;均<0.001)。CD133和巢蛋白的蛋白表达水平与Cho/Cr比值高度相关(分别为=0.897和=0.861)。

结论

Cho/Cr比值与高级别胶质瘤中CSLCs的分布相关,这可能有助于识别富含CSLCs的病灶,从而改善高级别胶质瘤的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/5b58f4ab0cba/ott-10-195Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/805e24ee0141/ott-10-195Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/b2b87f14018d/ott-10-195Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/1aad0e901a1f/ott-10-195Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/4adc97c1c086/ott-10-195Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/5b58f4ab0cba/ott-10-195Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/805e24ee0141/ott-10-195Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/b2b87f14018d/ott-10-195Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/1aad0e901a1f/ott-10-195Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/4adc97c1c086/ott-10-195Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/5221654/5b58f4ab0cba/ott-10-195Fig5.jpg

相似文献

1
Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas.多体素磁共振波谱术可识别高级别胶质瘤中癌干细胞样细胞的富集灶。
Onco Targets Ther. 2017 Jan 4;10:195-203. doi: 10.2147/OTT.S118834. eCollection 2017.
2
Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.使用混合 MR-PET 成像对脑胶质瘤进行代谢绘图:该方法的可行性和代谢变化的空间分布。
Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.
3
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.质子磁共振波谱在鉴别高级别脑胶质瘤与单发性脑转移瘤中的应用
Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901.
4
Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.使用磁共振波谱识别低级别胶质瘤中的间变性病灶。
Br J Neurosurg. 2014 Oct;28(5):631-6. doi: 10.3109/02688697.2013.872229. Epub 2013 Dec 30.
5
Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.磁共振波谱中的胆碱/肌酸(Cho/Cr)比值作为胶质瘤细胞增殖活性和预后的生物标志物:与微小染色体维持蛋白2表达的相关性
Acta Radiol. 2019 Jan;60(1):106-112. doi: 10.1177/0284185118770899. Epub 2018 Apr 17.
6
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.磁共振波谱在鉴别高级别与低级别胶质瘤中的诊断性能:一项系统评价和荟萃分析。
Eur Radiol. 2016 Aug;26(8):2670-84. doi: 10.1007/s00330-015-4046-z. Epub 2015 Oct 15.
7
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.使用定量表观扩散系数和质子磁共振波谱成像对脑胶质瘤术前肿瘤分级进行诊断检查性能的测量。
Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.
8
In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.在幕上胶质瘤分级评估中:多体素质子磁共振波谱和弥散张量成像的联合作用。
Clin Radiol. 2011 Oct;66(10):953-60. doi: 10.1016/j.crad.2011.05.001. Epub 2011 Jun 12.
9
Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.脑胶质瘤的质子磁共振波谱成像:代谢物比率与组织病理学分级的相关性
Chang Gung Med J. 2004 Jun;27(6):399-407.
10
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.多体素3D质子磁共振波谱在鉴别复发性胶质瘤与放射性损伤中的应用
J Neurooncol. 2007 Aug;84(1):63-9. doi: 10.1007/s11060-007-9341-3. Epub 2007 Feb 14.

引用本文的文献

1
Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.高级磁共振波谱神经影像学:专家共识建议。
NMR Biomed. 2021 May;34(5):e4309. doi: 10.1002/nbm.4309. Epub 2020 Apr 29.
2
Multivoxel H-MR Spectroscopy Biometrics for Preoprerative Differentiation Between Brain Tumors.用于脑肿瘤术前鉴别的多体素氢磁共振波谱生物特征分析
Tomography. 2018 Dec;4(4):172-181. doi: 10.18383/j.tom.2018.00051.
3
The biology and mathematical modelling of glioma invasion: a review.脑胶质瘤侵袭的生物学和数学建模:综述。

本文引用的文献

1
Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors.磁共振波谱学——重新审视脑肿瘤的生化和分子环境
BBA Clin. 2016 Apr 12;5:170-8. doi: 10.1016/j.bbacli.2016.04.002. eCollection 2016 Jun.
2
Metabolic Heterogeneity in Human Lung Tumors.人类肺部肿瘤中的代谢异质性
Cell. 2016 Feb 11;164(4):681-94. doi: 10.1016/j.cell.2015.12.034. Epub 2016 Feb 4.
3
Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.靶向恶性脑胶质瘤代谢脆弱性的新方法。
J R Soc Interface. 2017 Nov;14(136). doi: 10.1098/rsif.2017.0490.
Curr Neurol Neurosci Rep. 2016 Feb;16(2):17. doi: 10.1007/s11910-015-0613-6.
4
Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.胶质瘤手术中肿瘤轮廓勾画的代谢方法:三维磁共振波谱成像引导下的切除术
J Neurosurg. 2016 Jun;124(6):1585-93. doi: 10.3171/2015.6.JNS142651. Epub 2015 Dec 4.
5
Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence.胶质母细胞瘤的当前挑战:肿瘤内异质性、残留疾病以及预测疾病复发的模型
Front Oncol. 2015 Nov 16;5:251. doi: 10.3389/fonc.2015.00251. eCollection 2015.
6
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.磁共振波谱在鉴别高级别与低级别胶质瘤中的诊断性能:一项系统评价和荟萃分析。
Eur Radiol. 2016 Aug;26(8):2670-84. doi: 10.1007/s00330-015-4046-z. Epub 2015 Oct 15.
7
Cancer stem cells in glioblastoma.胶质母细胞瘤中的癌症干细胞。
Genes Dev. 2015 Jun 15;29(12):1203-17. doi: 10.1101/gad.261982.115.
8
Characterization of glioma stem-like cells from human glioblastomas.源自人胶质母细胞瘤的胶质瘤干细胞样细胞的特性分析
Int J Oncol. 2015 Jul;47(1):91-6. doi: 10.3892/ijo.2015.2992. Epub 2015 May 7.
9
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.CBTRUS统计报告:2007 - 2011年在美国诊断出的原发性脑和中枢神经系统肿瘤
Neuro Oncol. 2014 Oct;16 Suppl 4(Suppl 4):iv1-63. doi: 10.1093/neuonc/nou223.
10
MGMT testing--the challenges for biomarker-based glioma treatment.MGMT 检测——基于生物标志物的脑胶质瘤治疗面临的挑战。
Nat Rev Neurol. 2014 Jul;10(7):372-85. doi: 10.1038/nrneurol.2014.100. Epub 2014 Jun 10.